• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化位点突变方法研究 LRRK2,分别将磷酸化和去磷酸化与保护和有害标记联系起来。

A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.

机构信息

University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience and Cognition, F-59000 Lille, France.

Department of Cell Biochemistry, University of Groningen, 9747 AG Groningen, The Netherlands.

出版信息

Cells. 2022 Mar 17;11(6):1018. doi: 10.3390/cells11061018.

DOI:10.3390/cells11061018
PMID:35326469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8946913/
Abstract

The () gene is a major genetic determinant of Parkinson's disease (PD), encoding a homonymous multi-domain protein with two catalytic activities, GTPase and Kinase, involved in intracellular signaling and trafficking. LRRK2 is phosphorylated at multiple sites, including a cluster of autophosphorylation sites in the GTPase domain and a cluster of heterologous phosphorylation sites at residues 860 to 976. Phosphorylation at these latter sites is found to be modified in brains of PD patients, as well as for some disease mutant forms of LRRK2. The main aim of this study is to investigate the functional consequences of LRRK2 phosphorylation or dephosphorylation at LRRK2's heterologous phosphorylation sites. To this end, we generated LRRK2 phosphorylation site mutants and studied how these affected LRRK2 catalytic activity, neurite outgrowth and lysosomal physiology in cellular models. We show that phosphorylation of RAB8a and RAB10 substrates are reduced with phosphomimicking forms of LRRK2, while RAB29 induced activation of LRRK2 kinase activity is enhanced for phosphodead forms of LRRK2. Considering the hypothesis that PD pathology is associated to increased LRRK2 kinase activity, our results suggest that for its heterologous phosphorylation sites LRRK2 phosphorylation correlates to healthy phenotypes and LRRK2 dephosphorylation correlates to phenotypes associated to the PD pathological processes.

摘要

LRRK2 基因是帕金森病(PD)的主要遗传决定因素,编码一种具有两种催化活性(GTPase 和激酶)的同源多结构域蛋白,参与细胞内信号转导和运输。LRRK2 在多个位点发生磷酸化,包括 GTPase 结构域中的一组自身磷酸化位点和 860 到 976 残基处的一组异源磷酸化位点。研究发现,这些后一组位点的磷酸化在 PD 患者的大脑中以及某些 LRRK2 疾病突变形式中发生了改变。本研究的主要目的是研究 LRRK2 在其异源磷酸化位点上的磷酸化或去磷酸化对 LRRK2 的功能后果。为此,我们生成了 LRRK2 磷酸化位点突变体,并研究了这些突变如何影响细胞模型中的 LRRK2 催化活性、神经突生长和溶酶体生理学。我们表明,RAB8a 和 RAB10 底物的磷酸化减少了 LRRK2 的磷酸模拟形式,而 RAB29 诱导的 LRRK2 激酶活性的激活增强了 LRRK2 的磷酸化失活形式。考虑到 PD 病理学与 LRRK2 激酶活性增加相关的假设,我们的结果表明,对于其异源磷酸化位点,LRRK2 磷酸化与健康表型相关,而 LRRK2 去磷酸化与与 PD 病理过程相关的表型相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/7b160d86136f/cells-11-01018-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/886a76e50621/cells-11-01018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/bc740197a2b8/cells-11-01018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/c74c3ebbc310/cells-11-01018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/9ae08bb2e83b/cells-11-01018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/a16ceba2fa95/cells-11-01018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/b542bb44146f/cells-11-01018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/ed002bd3eed1/cells-11-01018-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/7b160d86136f/cells-11-01018-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/886a76e50621/cells-11-01018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/bc740197a2b8/cells-11-01018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/c74c3ebbc310/cells-11-01018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/9ae08bb2e83b/cells-11-01018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/a16ceba2fa95/cells-11-01018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/b542bb44146f/cells-11-01018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/ed002bd3eed1/cells-11-01018-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb52/8946913/7b160d86136f/cells-11-01018-g008.jpg

相似文献

1
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.磷酸化位点突变方法研究 LRRK2,分别将磷酸化和去磷酸化与保护和有害标记联系起来。
Cells. 2022 Mar 17;11(6):1018. doi: 10.3390/cells11061018.
2
Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes.内源性 Rab38 调节黑素细胞中 LRRK2 的膜募集和底物 Rab 磷酸化。
J Biol Chem. 2023 Oct;299(10):105192. doi: 10.1016/j.jbc.2023.105192. Epub 2023 Aug 23.
3
LRRK2 Phosphorylation.富含亮氨酸重复激酶2磷酸化
Adv Neurobiol. 2017;14:51-70. doi: 10.1007/978-3-319-49969-7_3.
4
LRRK2 Phosphorylation: Behind the Scenes.LRRK2 磷酸化:幕后故事。
Neuroscientist. 2018 Oct;24(5):486-500. doi: 10.1177/1073858418756309. Epub 2018 Jan 31.
5
Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation.蛋白磷酸酶 2A 全酶调节富含亮氨酸重复激酶 2 的磷酸化和积累。
Neurobiol Dis. 2021 Sep;157:105426. doi: 10.1016/j.nbd.2021.105426. Epub 2021 Jun 16.
6
Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes.Rab12是LRRK2的调节剂,且其由受损溶酶体激活。
Elife. 2023 Oct 24;12:e87255. doi: 10.7554/eLife.87255.
7
Rab29 activation of the Parkinson's disease-associated LRRK2 kinase.Rab29 激活帕金森病相关的 LRRK2 激酶。
EMBO J. 2018 Jan 4;37(1):1-18. doi: 10.15252/embj.201798099. Epub 2017 Dec 6.
8
LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a/Rab10-dependent manner.LRRK2 的磷酸化状态和激酶活性通过 Rab8a/Rab10 依赖性方式调节(大)自噬。
Cell Death Dis. 2023 Jul 15;14(7):436. doi: 10.1038/s41419-023-05964-0.
9
Phosphorylation of Rab29 at Ser185 regulates its localization and role in the lysosomal stress response in concert with LRRK2.Rab29 的丝氨酸 185 位点磷酸化与 LRRK2 共同调节其在溶酶体应激反应中的定位和作用。
J Cell Sci. 2023 Jul 15;136(14). doi: 10.1242/jcs.261003. Epub 2023 Jul 21.
10
Development of phospho-specific Rab protein antibodies to monitor activity of the LRRK2 Parkinson's disease kinase.开发磷酸化特异性 Rab 蛋白抗体以监测 LRRK2 帕金森病激酶的活性。
Biochem J. 2018 Jan 2;475(1):1-22. doi: 10.1042/BCJ20170802.

引用本文的文献

1
LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a/Rab10-dependent manner.LRRK2 的磷酸化状态和激酶活性通过 Rab8a/Rab10 依赖性方式调节(大)自噬。
Cell Death Dis. 2023 Jul 15;14(7):436. doi: 10.1038/s41419-023-05964-0.
2
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease.两种新型 LRRK2 致病性变异在家族性帕金森病中的功能分析。
Mov Disord. 2022 Aug;37(8):1761-1767. doi: 10.1002/mds.29124. Epub 2022 Jun 16.

本文引用的文献

1
Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.LRRK2 基因突变与帕金森病相关,将 Rab8a 隔离到受损的溶酶体中,并调节小胶质细胞中转铁蛋白介导的铁摄取。
PLoS Biol. 2021 Dec 16;19(12):e3001480. doi: 10.1371/journal.pbio.3001480. eCollection 2021 Dec.
2
Alpha-Synuclein and Lipids: The Elephant in the Room?α-突触核蛋白与脂质:房间里的大象?
Cells. 2021 Sep 17;10(9):2452. doi: 10.3390/cells10092452.
3
Impact of Type II LRRK2 inhibitors on signaling and mitophagy.
LRRK2 型抑制剂对信号转导和线粒体自噬的影响。
Biochem J. 2021 Oct 15;478(19):3555-3573. doi: 10.1042/BCJ20210375.
4
Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation.蛋白磷酸酶 2A 全酶调节富含亮氨酸重复激酶 2 的磷酸化和积累。
Neurobiol Dis. 2021 Sep;157:105426. doi: 10.1016/j.nbd.2021.105426. Epub 2021 Jun 16.
5
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.R1441G 突变而非 G2019S 突变增强了人外周血中性粒细胞中 LRRK2 介导的 Rab10 磷酸化。
Acta Neuropathol. 2021 Sep;142(3):475-494. doi: 10.1007/s00401-021-02325-z. Epub 2021 Jun 14.
6
Structural analysis of the full-length human LRRK2.全长人 LRRK2 的结构分析。
Cell. 2021 Jun 24;184(13):3519-3527.e10. doi: 10.1016/j.cell.2021.05.004. Epub 2021 Jun 8.
7
Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells.注意差距:LRRK2 表型在临床与患者细胞中的差异。
Cells. 2021 Apr 22;10(5):981. doi: 10.3390/cells10050981.
8
Preclinical modeling of chronic inhibition of the Parkinson's disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo.帕金森病相关激酶 LRRK2 的慢性抑制的临床前模型研究揭示了内溶酶体系统在体内功能的改变。
Mol Neurodegener. 2021 Mar 19;16(1):17. doi: 10.1186/s13024-021-00441-8.
9
LRRK2 mediates tubulation and vesicle sorting from lysosomes.LRRK2 介导从溶酶体的小管形成和囊泡分拣。
Sci Adv. 2020 Nov 11;6(46). doi: 10.1126/sciadv.abb2454. Print 2020 Nov.
10
Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues.G2019S 和 R1441C LRRK2 突变对小鼠组织中 LRRK2 和 Rab10 磷酸化的不同影响。
Cells. 2020 Oct 22;9(11):2344. doi: 10.3390/cells9112344.